NKTR · Nektar Therapeutics
$73.02
-2.90 (-3.82%)
At close · Aug 14
Market Cap
$2.49B
Shares
34.14M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-05-08 | — | $150,000,000 | — | — | 10-Q , filed 2026-08-14 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-13 |
| 2024-12-31 | $3,000,000 | 10-K, filed 2026-03-13 |
| 2023-12-31 | $0 | 10-K, filed 2025-03-14 |
Key facts
CIK
906709
CUSIP
640268306
13F (30d)
250 filings
235 filers
Visit website
Investor relations